IP Verse

Combination Therapy For The Treatment Of Cancer - EP3033086

PATENT ANALYSIS

Patent Details

Grant Date
Sep 22, 2021
Company
NOVARTIS AG
Oppositions

BACHELIN, MARTIN

GENERICS [UK] LIMITED

HOFFMANN EITLE PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBB

STADA-ARZNEIMITTEL AKTIENGESELLSCHAFT

TEVA PHARMACEUTICAL INDUSTRIES, LTD.

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you